Menopausal Hormone Therapy in Gynecologic Cancer Survivors: A Review of the Evidence and Practice Recommendations

Ekta Kapoor, Daniel Benrubi, Stephanie S. Faubion

Research output: Contribution to journalReview article

1 Scopus citations

Abstract

Gynecologic cancers are common in the United States and represent a significant health burden. Treatment of these cancers often causes premature cessation of ovarian function, with resultant symptoms that are often more severe than those associated with natural menopause. Hormone therapy is the most effective treatment for menopausal symptoms, but the decision-making process about its use can be complex for survivors of gynecologic cancer. In this review, we provide evidence-based recommendations about the use of hormone therapy after gynecologic cancer.

Original languageEnglish (US)
Pages (from-to)488-495
Number of pages8
JournalClinical Obstetrics and Gynecology
Volume61
Issue number3
DOIs
StatePublished - Sep 1 2018

Keywords

  • endometrial cancer
  • gynecologic cancer
  • hormone therapy
  • menopause
  • ovarian cancer

ASJC Scopus subject areas

  • Obstetrics and Gynecology

Fingerprint Dive into the research topics of 'Menopausal Hormone Therapy in Gynecologic Cancer Survivors: A Review of the Evidence and Practice Recommendations'. Together they form a unique fingerprint.

  • Cite this